Zobrazeno 1 - 10
of 19
pro vyhledávání: '"VANIA MASLARSKA"'
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-10 (2024)
The COVID-19 pandemic has raised many questions regarding the control and therapy of type 2 diabetes and the higher risk of severe disease progression. One of the therapeutic regimens used in moderate and severe cases of COVID-19, endorsed by the Wor
Externí odkaz:
https://doaj.org/article/5889ca45b0ad4c5abc3ffe56c1286b6d
Autor:
Vania Maslarska, Lily Peikova, Maya Georgieva, Stefka Ivanova, Miglena Smerikarova, Stefan Balkanski, Stanislav Bozhanov
Publikováno v:
Pharmacia, Vol 70, Iss 3, Pp 681-688 (2023)
Background: The contemporary treatment of ulcerogenic diseases and gastroesophageal reflux disease is related usually to application of a combination of imidazole-based antibacterial, antibiotic and proton pump inhibitor. In the current study, the th
Externí odkaz:
https://doaj.org/article/4a37d2ef7b2b45408bdea98692d83451
Autor:
Vania Maslarska, Stanislav Bozhanov, Stanislava Vladimirova, Lily Peikova, Diana Tzankova, Maya Georgieva
Publikováno v:
Pharmacia, Vol 69, Iss 2, Pp 265-271 (2022)
A simple, fast and selective stability indicating RP-HPLC method was applied for following the degradation and appearance of impurities of previously synthesized 2-(5-(4-chlorophenyl)-3-(ethoxycarbonyl)-2-methyl-1H-pyrrol-1-yl)propanoic acid. The chr
Externí odkaz:
https://doaj.org/article/4b0bfaa3012a4752bc7c1b4d952a05da
Autor:
Meri Amerikova, Ivanka Pencheva El-Tibi, Vania Maslarska, Stanislav Bozhanov, Konstantin Tachkov
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 33, Iss 1, Pp 671-682 (2019)
Bioactive compounds, such as antimicrobial peptides (AMPs), have increasingly been used recently to counteract the rapidly increasing incidence of bacterial resistance to usual antibiotics and chemotherapeutics. In humans, endogenous AMPs are part of
Externí odkaz:
https://doaj.org/article/4c78145226714c818626864c0bcd1637
Publikováno v:
International Journal of Applied Pharmaceutics. :14-21
Transthyretin kinetic stabilizers are used as first-line drug therapy for transthyretin amyloid polyneuropathy mostly in patients unsuitable for liver transplantation. The two drugs prescribed in clinical practice are Tafamidis and Diflunisal. The Eu
Autor:
Marta Slavkova, Teodora Popova, Christina Voycheva, Stanislav Bozhanov, Vania Maslarska, Milen Dimitrov
Publikováno v:
Research Journal of Pharmacy and Technology. :6345-6352
The need for additional fluids for easy absorption is typical for elderly patients and those with dysphagia. Most often, these patients take their medication with a glass of orange juice or another liquid instead of a glass of water. We conducted a d
Publikováno v:
Journal of Chromatographic Science. 60:840-847
Present study describes a high-performance liquid chromatography method for the determination of the potent kinetic stabilizer—Tafamidis in human plasma. It was approved for medical use in European Union in 2011. Ultra violet (UV) detection mode an
Publikováno v:
Current Pharmaceutical Analysis. 17:528-536
Background: The indole-containing aroylhydrazone derivatives 3a-c with potent antimycobacterial activity against a referent strain M. tuberculosis H37Rv and low cytotoxicity were evaluated for their stability via the precise and accurate HPLC analyti
Publikováno v:
International Journal of Applied Pharmaceutics. :253-256
Objective: The popularity of Sildenafil, the widespread distribution of various products and dietary supplements with added synthetic drugs, requires reliable analysis methods. This research study aimed to develop a simple isocratic HPLC method for t
Publikováno v:
Current Analytical Chemistry. 16:208-222
Background: Sartans are mostly used as a part of combination with additional medicines in the therapy of essencial hypertension. Preferred combinations are ARB and thiazide diuretics (Hydrochlorothiazide (HCT) and Chlorthalidone (CHL)) or ARB and cal